Radiology, Vol 195, 345-352, Copyright © 1995 by Radiological Society of North America

ARTICLES

Evaluation of pancreatic tumors with positron emission tomography and F- 18 fluorodeoxyglucose: comparison with CT and US

T Inokuma, N Tamaki, T Torizuka, Y Magata, M Fujii, Y Yonekura, T Kajiyama, G Ohshio, M Imamura and J Konishi
Department of Nuclear Medicine, Kyoto University Faculty of Medicine, Japan.

PURPOSE: To assess the clinical value of positron emission tomography (PET) with fluorine-18-labeled fluorodeoxyglucose (FDG) for identification of pancreatic carcinoma. MATERIALS AND METHODS: Forty- six patients suspected of having a pancreatic neoplasm and who were to undergo surgery prospectively underwent FDG PET, computed tomography (CT), and transabdominal ultrasound (US). Endoscopic US was performed in 40 patients. Images were independently interpreted and compared with the histopathologic findings at surgery (41 patients) or with clinical follow-up findings (five patients). RESULTS: In 33 of 35 patients, foci of pancreatic carcinomas (10-100 mm in diameter) were identified as an increase in FDG uptake, whereas CT, transabdominal US, and endoscopic US depicted the foci in 31, 31, and 28, cases, respectively. Among 11 benign lesions, nine showed no increased FDG uptake (specificity = 82%). Specificities of the other modalities were lower. False-positive findings were obtained in a case of chronic active pancreatitis and in a serous cystadenoma. CONCLUSION: FDG PET, which provides "biochemical" information, is accurate in identifying pancreatic carcinoma and may be a method of choice when imaging equivocal masses detected with other "anatomic" imaging studies.

This article has been cited by other articles:

				B B Chin and R L Wahl 18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies Gut, June 1, 2003; 52(90004): iv23 - 29. [Abstract] [Full Text] [PDF]

				M. F. Kalady, B. M. Clary, L. A. Clark, M. Gottfried, E. M. Rohren, R. E. Coleman, T. N. Pappas, and D. S. Tyler Clinical Utility of Positron Emission Tomography in the Diagnosis and Management of Periampullary Neoplasms Ann. Surg. Oncol., October 1, 2002; 9(8): 799 - 806. [Abstract] [Full Text] [PDF]

				A Meining, H J Dittler, A Wolf, R Lorenz, V Schusdziarra, J-R Siewert, M Classen, H Hofler, and T Rosch You get what you expect? A critical appraisal of imaging methodology in endosonographic cancer staging Gut, May 1, 2002; 50(5): 599 - 603. [Abstract] [Full Text] [PDF]

				T. Higashi, T. Saga, Y. Nakamoto, T. Ishimori, M. H. Mamede, M. Wada, R. Doi, R. Hosotani, M. Imamura, and J. Konishi Relationship Between Retention Index in Dual-Phase 18F-FDG PET, and Hexokinase-II and Glucose Transporter-1 Expression in Pancreatic Cancer J. Nucl. Med., February 1, 2002; 43(2): 173 - 180. [Abstract] [Full Text] [PDF]

				A. C. Buck, H. H. Schirrmeister, C.-A. Guhlmann, C. G. Diederichs, C. Shen, I. Buchmann, J. Kotzerke, D. Birk, T. Mattfeldt, and S. N. Reske Ki-67 Immunostaining in Pancreatic Cancer and Chronic Active Pancreatitis: Does In Vivo FDG Uptake Correlate with Proliferative Activity? J. Nucl. Med., May 1, 2001; 42(5): 721 - 725. [Abstract] [Full Text]

				S. S. Gambhir, J. Czernin, J. Schwimmer, D. H. S. Silverman, R. E. Coleman, and M. E. Phelps A Tabulated Summary of the FDG PET Literature J. Nucl. Med., May 1, 2001; 42(90050): 1S - 93. [Full Text] [PDF]

				P. G. Rose, L. P. Adler, M. Rodriguez, P. F. Faulhaber, F. W. Abdul-Karim, and F. Miraldi Positron Emission Tomography for Evaluating Para-aortic Nodal Metastasis in Locally Advanced Cervical Cancer Before Surgical Staging: A Surgicopathologic Study J. Clin. Oncol., January 1, 1999; 17(1): 41 - 41. [Abstract] [Full Text] [PDF]